The Pharmacy and Poison Board has warned of the distribution and consumption of Tamedol, a paracetamol solution that is in circulation.
The board says the solution has not met the required threshold and is cautioning both consumers and pharmacies against its use and sale.
PPB says following several complaints regarding quality defects and falsified batches, the solution is recalled with immediate effect.
The board said the product manufactured by Biopharma Limited must be quarantined immediately.
“Stop all further distribution, sale, issuing, or use of Tamedol oral solution,” the agency stated said.
“Members of the public are urged to return the product to their nearest healthcare facility, while healthcare facilities are instructed to return the products to their respective suppliers.”
PPB urged the public at large to exercise constant vigilance and to report any suspected instances of substandard medications.
It also urged the public to report any negative drug responses as soon as possible to the nearest medical facility.